Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 458
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 98
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,424 Results (Page 57 of 122)
- Relevance
  Sort by

Biosimilar Interleukins Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3970EUR$4,490USD£3,427GBP

Transdermal Skin Patches Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3970EUR$4,490USD£3,427GBP

Effervescent Tablet Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3970EUR$4,490USD£3,427GBP

Nasal Drug Delivery Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3970EUR$4,490USD£3,427GBP

Contract Injectable Packaging Trends in the Bio/Pharma Industry

 Report
August 2022
96 Pages
Global

From

€4416EUR$4,995USD£3,813GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Breast Cancer Drugs Market Size, Share & Trends Analysis Report By Therapy (Targeted, Hormonal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Cancer Type (Hormone Receptor, HER2+), And Segment Forecasts, 2023-2030

 Report
June 2023
180 Pages
Global

From

€5261EUR$5,950USD£4,542GBP

Eosinophilic Esophagitis - Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Stratergies and Forecast, 2020 - 2030

 Drug Pipelines
January 2022
84 Pages
Global

From

€8837EUR$9,995USD£7,629GBP

Biologic & Biosimilar RA Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3970EUR$4,490USD£3,427GBP

Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
July 2023
260 Pages
Global

From

€2166EUR$2,450USD£1,870GBP

Molecular Diagnostics for Cancer: Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides

 Report
August 2025
448 Pages
Global

From

€6185EUR$6,995USD£5,339GBP

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
152 Pages
Global

From

€3095EUR$3,500USD£2,672GBP

Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

 Drug Pipelines
June 2022
101 Pages
Global

From

€13258EUR$14,995USD£11,446GBP

Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q2 2022 - Thematic Research

 Report
July 2022
25 Pages
Global

From

€1724EUR$1,950USD£1,488GBP

Biopharmaceuticals - A Global Market Overview

 Report
February 2025
225 Pages
Global

From

€3979EUR$4,500USD£3,435GBP

AI in Clinical Trials Market (2nd Edition): AI Software and Service Providers - Distribution by Trial Phase, Target Therapeutic Area, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
July 2023
304 Pages
Global

From

€4243EUR$4,799USD£3,663GBP

Bipolar Disorder Therapeutics Market 2024-2028

 Report
November 2023
161 Pages
Global

From

€2210EUR$2,500USD£1,908GBP

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
67 Pages
Global

From

€3095EUR$3,500USD£2,672GBP

Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
72 Pages
Global

From

€1768EUR$2,000USD£1,527GBP

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
42 Pages
Global

From

€3095EUR$3,500USD£2,672GBP

Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7029EUR$7,950USD£6,068GBP

2,424 Results (Page 57 of 122)
- 1
- 55
- 56
- 57
- 58
- 59

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.